AbbVie

US · ABBV #30 by market cap Listed 1970

271.19 -0.17 -0.06%

Live - 5344 symbols - heartbeat 252s ago · 2026-10-08 14:50

Pre-market 270.54 -0.30%

After-hours 272.56 +0.44%

Overnight 271.28 -0.03%

Market cap: 479.22B
P/E (TTM): 76.61
P/B: -80.74
EPS: 2.36
Div yield: 2.49%
52W pos: 96%

Reader sentiment Are you bullish or bearish on ABBV?

Anonymous reader poll. Unscientific, not investment advice.

About AbbVie

AbbVie is a biopharmaceutical company focused on immunology (rheumatology, gastroenterology and dermatology), oncology including blood cancers, virology, neuroscience conditions such as Parkinson's disease, and other specialty areas. It was spun off from Abbott Laboratories in October 2011 and is headquartered in North Chicago, Illinois.

Founded: 2011
CEO: Mr. Robert A. Michael
Employees: 57,000
Headquarters: North Chicago, Illinois, United States of America
Fiscal year end: 12-31
Website: abbvie.com

Company profile

Exchange: US
Symbol: ABBV
Market-cap rank: #30
Listing date: 1970-01-01
Market cap: 479.22B
Float cap: 478.38B
Shares out: 1.77B
Float shares: 1.76B

Sectors & themes

Drug Manufacturers - General Government Pension Fund of Norway Global medical industry US New Economic Stocks Regular Savings Plan Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 14:50:08 · For reference only, not investment advice and not tailored to your situation.